FoxP3 T cells and the pathophysiologic effects of brain death and warm ischemia in donor kidneys

Clinical Journal of the American Society of Nephrology

Volumn 7, Issue 9, 2012, Pages 1481-1489

  Baan, Carla C ^a   Peeters, Annemiek M A ^a   Demmers, Martijn W H J ^a   Mol, Wendy M ^a   Boer, Karin ^a   Samsom, Janneke N ^a   Rowshani, Ajda T ^a   Ijzermans, Jan N M ^a   Weimar, Willem ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 8; KIDNEY INJURY MOLECULE 1; MESSENGER RNA; RETINOID RELATED ORPHAN RECEPTOR GAMMA; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BRAIN DEATH; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CRYOPRESERVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; KIDNEY BIOPSY; KIDNEY DONOR; KIDNEY TUBULE CELL; REGULATORY T LYMPHOCYTE;

ADULT; AGED; ANTIGENS, CD3; BIOLOGICAL MARKERS; BIOPSY; BRAIN DEATH; CELLS, CULTURED; COCULTURE TECHNIQUES; CREATININE; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; GRAFT SURVIVAL; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INFLAMMATION MEDIATORS; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKIN-8; KIDNEY; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; RECEPTORS, VIRUS; RNA, MESSENGER; T-LYMPHOCYTES, REGULATORY; TH17 CELLS; TIME FACTORS; WARM ISCHEMIA;

EID: 84866127553     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.13041211     Document Type: Article

References (27)

1. Stangl M, Zerkaulen T, Theodorakis J, Illner W, Schneeberger H, Land W, Faist E: Influence of brain death on cytokine release in organ donors and renal transplants. Transplant Proc 33: 1284-1285, 2001
2. Lopau K, Mark J, SchrammL, Heidbreder E, WannerC:Hormonal changes in brain death and immune activation in the donor. Transpl Int 13[Suppl 1]: S282-S285, 2000
3. Barklin A: Systemic inflammation in the brain-dead organ donor. Acta Anaesthesiol Scand 53: 425-435, 2009
4. Novitzky D, Horak A, Cooper DK, Rose AG: Electrocardiographic and histopathologic changes developing during experimental brain death in the baboon. Transplant Proc 21: 2567-2569, 1989
5. Pratschke J, Neuhaus P, Tullius SG: What can be learned from brain-death models? Transpl Int 18: 15-21, 2005
6. Lemay S, Rabb H, Postler G, Singh AK: Prominent and sustained up-regulation of gp130-signaling cytokines and the chemokine MIP-2 in murine renal ischemia-reperfusion injury. Transplantation 69: 959-963, 2000
7. Ascon M, Ascon DB, Liu M, Cheadle C, Sarkar C, Racusen L, Hassoun HT, Rabb H: Renal ischemia-reperfusion leads to long term infiltration of activated and effector-memory T lymphocytes. Kidney Int 75: 526-535, 2009
8. Moore FA, Sauaia A, Moore EE, Haenel JB, Burch JM, Lezotte DC: Postinjury multiple organ failure: A bimodal phenomenon. J Trauma 40: 501-510, 1996
9. Murphy TJ, Ni ChoileainN, Zang Y, Mannick JA, Lederer JA: CD4 +CD25+ regulatory T cells control innate immune reactivity after injury. J Immunol 174: 2957-2963, 2005
10. Gandolfo MT, Jang HR, Bagnasco SM, Ko GJ, Agreda P, Satpute SR, Crow MT, King LS, Rabb H: Foxp3+ regulatory T cells participate in repair of ischemic acute kidney injury. Kidney Int 76: 717-729, 2009
11. Bettelli E, Carrier Y, GaoW, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK: Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238, 2006
12. Zhang PL, Rothblum LI, Han WK, Blasick TM, Potdar S, Bonventre JV: Kidney injury molecule-1 expression in transplant biopsies is a sensitive measure of cell injury. Kidney Int 73: 608-614, 2008
13. Lemos FBC, Ijzermans JNM, Zondervan PE, Peeters AMA, van den Engel S, Mol WM, Weimar W, Baan CC: Differential expression of heme oxygenase-1 and vascular endothelial growth factor in cadaveric and living donor kidneys after ischemiareperfusion. J Am Soc Nephrol 14: 3278-3287, 2003
14. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, Weaver CT: Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6: 1123-1132, 2005
15. Chen Y, Wood KJ: Interleukin-23 and TH17 cells in transplantation immunity: Does 23+17 equal rejection? Transplantation 84: 1071-1074, 2007
16. Yoshida S, Haque A, Mizobuchi T, Iwata T, Chiyo M, Webb TJ, Baldridge LA, Heidler KM, Cummings OW, Fujisawa T, Blum JS, Brand DD, Wilkes DS: Anti-type V collagen lymphocytes that express IL-17 and IL-23 induce rejection pathology in fresh and well-healed lung transplants. Am J Transplant 6: 724-735, 2006
17. Gorbacheva V, Fan R, Li X, Valujskikh A: Interleukin-17 promotes early allograft inflammation. Am J Pathol 177: 1265-1273, 2010
18. Loong CC, Hsieh HG, Lui WY, Chen A, Lin CY: Evidence for the early involvement of interleukin 17 in human and experimental renal allograft rejection. J Pathol 197: 322-332, 2002
19. Van Kooten C, Boonstra JG, Paape ME, Fossiez F, Banchereau J, Lebecque S, Bruijn JA, De Fijter JW, Van Es LA, Daha MR: Interleukin-17 activates human renal epithelial cells in vitro and is expressed during renal allograft rejection. J Am Soc Nephrol 9: 1526-1534, 1998
20. Deteix C, Attuil-Audenis V, Duthey A, Patey N, McGregor B, Dubois V, Caligiuri G, Graff-Dubois S, Morelon E, Thaunat O: Intragraft Th17 infiltrate promotes lymphoid neogenesis and hastens clinical chronic rejection. J Immunol 184: 5344-5351, 2010
21. Zhou L, Lopes JE, ChongMM, Ivanov II, Min R, Victora GD, Shen Y, Du J, Rubtsov YP, Rudensky AY, Ziegler SF, Littman DR: TGFb-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 453: 236-240, 2008
22. Offner H, Subramanian S, Parker SM, Wang C, Afentoulis ME, Lewis A, Vandenbark AA, Hurn PD: Splenic atrophy in experimental stroke is accompanied by increased regulatory T cells and circulating macrophages. J Immunol 176: 6523-6531, 2006
23. Ni Choileain N, MacConmara M, Zang Y, Murphy TJ, Mannick JA, Lederer JA: Enhanced regulatory T cell activity is an element of the host response to injury. J Immunol 176: 225-236, 2006
24. Veronese F, Rotman S, Smith RN, Pelle TD, Farrell ML, Kawai T, Benedict Cosimi A, Colvin RB: Pathological and clinical correlates of FOXP3+ cells in renal allografts during acute rejection. Am J Transplant 7: 914-922, 2007
25. BattagliaM, Stabilini A, Migliavacca B, Horejs-Hoeck J, Kaupper T, Roncarolo MG: Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients. J Immunol 177: 8338-8347, 2006
26. Sewgobind VD, van der Laan LJ, Kho MM, Kraaijeveld R, Korevaar SS, Mol W, Weimar W, Baan CC: The calcineurin inhibitor tacrolimus allows the induction of functional CD4CD25 regulatory T cells by rabbit anti-thymocyte globulins. Clin Exp Immunol 161: 364-377, 2010
27. KinseyGR, Sharma R, Huang L, Li L, Vergis AL, Ye H, Ju ST, Okusa MD: Regulatory T cells suppress innate immunity in kidney ischemia-reperfusion injury. J Am Soc Nephrol 20: 1744-1753, 2009